Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery

Completed · Phase 2

Conditions studied: Venous Thrombosis

In brief

To study the safety and effectiveness of several doses of PD 0348292 compared to enoxaparin in preventing blood clots in the lungs or deep leg veins of patients after knee surgery

Key facts

Study ID

NCT00306254

Run by

Pfizer

People needed

1225

Starts

2006-03-01

Expected to finish

2007-07-01

Last updated by the study team

2007-10-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult men or women scheduled for an elective, unilateral total knee replacement who are otherwise healthy.

You may not qualify if…

• History of deep vein thrombosis or pulmonary embolism, suspected postthrombotic state, bleeding or clotting disorders, or cardiovascular, renal or liver disease within the past year

Where it is running

• Pfizer Investigational Site — Birmingham, Alabama, United States
• Pfizer Investigational Site — Little Rock, Arkansas, United States
• Pfizer Investigational Site — North Little Rock, Arkansas, United States
• Pfizer Investigational Site — Encinitas, California, United States
• Pfizer Investigational Site — Fountain Valley, California, United States
• Pfizer Investigational Site — Fountain Valley, California, United States
• Pfizer Investigational Site — Glendale, California, United States
• Pfizer Investigational Site — La Mesa, California, United States
• Pfizer Investigational Site — Long Beach, California, United States
• Pfizer Investigational Site — Long Beach, California, United States
• Pfizer Investigational Site — Long Beach, California, United States
• Pfizer Investigational Site — Los Angeles, California, United States
• Pfizer Investigational Site — Los Angeles, California, United States
• Pfizer Investigational Site — Los Angeles, California, United States
• Pfizer Investigational Site — Santa Ana, California, United States
• Pfizer Investigational Site — Torrance, California, United States
• Pfizer Investigational Site — Aurora, Colorado, United States
• Pfizer Investigational Site — Aurora, Colorado, United States
• Pfizer Investigational Site — Aurora, Colorado, United States
• Pfizer Investigational Site — Denver, Colorado, United States
• Pfizer Investigational Site — Englewood, Colorado, United States
• Pfizer Investigational Site — Littleton, Colorado, United States
• Pfizer Investigational Site — Littleton, Colorado, United States
• Pfizer Investigational Site — Lone Tree, Colorado, United States
• Pfizer Investigational Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.